The International Tennis Federation has banned Russia's Maria Sharapova for two years after she was found guilty of using a prohibited substance.
The 29-year old top Russian Tennis player came out to confess that she tested positive to a banned
substance (meldonium) after this year's Australian Open, and was provisionally suspended by the organisation in March, awaiting her final judgement.
Meldonium only became a banned substance for tennis player on January 1, 2016, while Sharapova said she's been taking the drug for heart issues since 2006.
Meanwhile, the five-time Grand Slam winner has disclosed that she will appeal the her final judgement; saying "cannot accept" the "unfairly harsh" ban.
Sharapova will challenge the suspension, which is backdated to 26 January 2016, at the Court of Arbitration for Sport (Cas).
In a statement, she said the tribunal concluded her offence was "unintentional" and that she had not tried to use a "performance-enhancing substance".
But she claimed the ITF had asked the tribunal to impose a four-year ban, adding it "spent tremendous amounts of time and resources trying to prove I intentionally violated the anti-doping rules".
The tribunal ruling said Sharapova tested positive for meldonium in an out-of competition test on 2 February, as well as in the aftermath of her Australian Open quarter-final defeat by Serena Williams on 26 January. It treated both results as a single anti-doping violation.
The London 2012 Olympic silver medallist added: "I have missed playing tennis and I have missed my amazing fans... your love and support has gotten me through these tough days.
"I intend to stand for what I believe is right and that's why I will fight to be back on the tennis court as soon as possible."
The ITF will not appeal against the tribunal's decision.
Nike, which suspended its relationship with Sharapova in January, said it would "continue to partner" the Russian, based on the tribunal's findings.
Sharapova was Forbes' highest-paid female athlete for 11 consecutive years, until Williams moved above her this year. The American made £28.9m from winnings and endorsements to Sharapova's £21.9m.
Aged 17, Sharapova became the first Russian to win Wimbledon in 2004, added the US Open in 2006 and the Australian Open in 2008, before completing a career Grand Slam with the French Open title in 2012.
She won the French Open again in 2014, but the 2018 tournament in Paris is the next major Sharapova can enter, when she will be 31.
The World Anti-Doping Agency (Wada) said in April that scientists were unsure how long meldonium stayed in the system, and suggested athletes who tested positive before 1 March could avoid bans, provided they had stopped taking it before 1 January.
However, Sharapova had already admitted she continued taking the substance past that date, saying she was unaware it had been added to the banned list as she knew it by another name - mildronate. BBC
The 29-year old top Russian Tennis player came out to confess that she tested positive to a banned
Meldonium only became a banned substance for tennis player on January 1, 2016, while Sharapova said she's been taking the drug for heart issues since 2006.
Meanwhile, the five-time Grand Slam winner has disclosed that she will appeal the her final judgement; saying "cannot accept" the "unfairly harsh" ban.
Sharapova will challenge the suspension, which is backdated to 26 January 2016, at the Court of Arbitration for Sport (Cas).
In a statement, she said the tribunal concluded her offence was "unintentional" and that she had not tried to use a "performance-enhancing substance".
But she claimed the ITF had asked the tribunal to impose a four-year ban, adding it "spent tremendous amounts of time and resources trying to prove I intentionally violated the anti-doping rules".
The tribunal ruling said Sharapova tested positive for meldonium in an out-of competition test on 2 February, as well as in the aftermath of her Australian Open quarter-final defeat by Serena Williams on 26 January. It treated both results as a single anti-doping violation.
The London 2012 Olympic silver medallist added: "I have missed playing tennis and I have missed my amazing fans... your love and support has gotten me through these tough days.
"I intend to stand for what I believe is right and that's why I will fight to be back on the tennis court as soon as possible."
The ITF will not appeal against the tribunal's decision.
Nike, which suspended its relationship with Sharapova in January, said it would "continue to partner" the Russian, based on the tribunal's findings.
Sharapova was Forbes' highest-paid female athlete for 11 consecutive years, until Williams moved above her this year. The American made £28.9m from winnings and endorsements to Sharapova's £21.9m.
Aged 17, Sharapova became the first Russian to win Wimbledon in 2004, added the US Open in 2006 and the Australian Open in 2008, before completing a career Grand Slam with the French Open title in 2012.
She won the French Open again in 2014, but the 2018 tournament in Paris is the next major Sharapova can enter, when she will be 31.
The World Anti-Doping Agency (Wada) said in April that scientists were unsure how long meldonium stayed in the system, and suggested athletes who tested positive before 1 March could avoid bans, provided they had stopped taking it before 1 January.
However, Sharapova had already admitted she continued taking the substance past that date, saying she was unaware it had been added to the banned list as she knew it by another name - mildronate. BBC
Maria Sharapova Set To Appeal Her Two Year Ban For Failed Drug Test
Reviewed by Unknown
on
10:22:00
Rating:
Reviewed by Unknown
on
10:22:00
Rating:
No comments: